Changes in Labeling Statin Drugs – What the New FDA Draft Guidance Says
By Staff Editor
Date: April 16, 2012
On Feb 28 2012, the FDA released new draft guidance on safety changes for widely used cholesterol – lowering or statin drugs. These regulations aim to educate, update health care professionals and patients about the health benefits as well as risks associated with these drugs.